SystemCommercial

The complete guide · November 2026

Call note compliance monitoring, explained.

After each visit to a doctor, a drug company's sales representative writes or dictates a short note in the company's customer system. Most of those notes are harmless. A few record a dinner offered in return for new patients, a question about an unapproved use, or a claim the label cannot support. Call note compliance monitoring is the work of finding those few while the company can still act on them.

This guide is for anyone who runs, reads, answers for or pays for this work: commercial and field compliance teams, compliance investigators, the Medical Information team, sales leaders, commercial operations, and the leaders deciding whether to automate it. No background needed.

See one case, screen by screen →
Watch with transcript →
A quick example · fictional

Imagine you are the field compliance lead at a mid-size biotech with 612 sales representatives. It is Wednesday, October 7, 2026, a little after 10 a.m. Yesterday at 2:20 p.m., one of your reps, Sam Patel, visited Dr. Ruiz, a dermatologist at Aldervale Pediatric & Adult Dermatology in Denver. He dictated his note the next morning, 17 hours and 45 minutes later: a minute and 48 seconds of audio, eleven sentences, mostly about skin clearance results and a health plan that keeps saying no.

Sentence 3 reads: "Before I left I told her Cobbleford would sponsor a dinner for her whole practice at Cinderbrook Grill once she moves her next three new psoriasis patients onto Veltrimab."

Your keyword list
Sentence 3
No listed word
Practice name
"pediatric": flagged
Result
One false alarm
A person reading the sentence
Offered by
Sam Patel
To, and what
Dr. Ruiz's practice, a dinner
In return for
Three new patients
No listed wordA possible kickbackand your policy gives one business day.

Nothing is booked yet, so the company can still stop it. Your policy says the clock began at the call, so 4 hours and 15 minutes remain.

Careful monitoring catches the offer while it is still only words, and sends it to the investigators with the four facts they need: who offered, to whom, what and in return for what.

Call note compliance monitoring guide
Part A · Understand it

Reading pharma call notes for kickback risk, off-label requests and promotional claims: the work and the 2026 rules

What a call note holds, which rules reach it, why word lists miss what matters, what recent settlements show, and how teams do this today, explained without selling anything. If you are new to commercial compliance, start here.

01 · In plain words

What a call note is, and why a compliance team wants to read it

A drug company's sales representative spends the day visiting doctors. Each visit is called a call. After each call, the rep records what happened in the company's customer relationship management system, or CRM: who they saw, which products they discussed, how many samples they left, and a few free sentences in their own words. Those sentences are the call note. Many reps now dictate them into the CRM app, in the car, between visits.

Nobody writes a call note thinking of the compliance team. A rep writes it to remember the next visit and to show a manager that the visit happened. So the note tends to say plainly what occurred. "She asked if she could use it in a teenager." "I told him it works faster than anything else." "I said we'd bring lunch for her whole staff once she has five patients on it." These sentences are unguarded, and that makes them useful.

Each of those three sentences asks something of the company. A question about a use the label does not cover should go to the medical team, which answers in writing. A claim the label cannot support needs correcting with the rep. An offer of value tied to prescribing may break a federal criminal law, and it should reach the people who investigate such things before anyone buys the lunch.

A large field force files thousands of these notes every week. Compliance teams have usually read a sample, weeks later, often with a list of risky words to help them choose. Call note compliance monitoring is the name for this reading, however it is done. The rest of Part A explains what to look for, which rules apply, and where the usual method falls short.

From a doctor's office to a coached rep: a call note in five steps

  1. The visitTuesday, 2:20 p.m. A rep sees a dermatologist for twelve minutes and, on the way out, offers to sponsor a dinner.
  2. The noteThe rep dictates what happened the next morning. The note lands in the CRM with hundreds of others.
  3. Someone reads itReader, sample or word list: this is where the offer is found, or left unread.
  4. It goes to the right teamInvestigators for the offer, Medical Information for the question, a compliance reviewer for the claim.
  5. A person decides, and the record staysAn investigator opens a case, the rep is coached, and the note, the decision and the reason remain on file.

Step 3 is the subject of this guide. The people and dates in this example are fictional.

An unbooked dinner can count, and three more surprises in call notes

An offer is enough

The Anti-Kickback Statute reaches anyone who "offers or pays" to induce a federally reimbursed purchase.1 A dinner that was promised and never eaten can still matter, which is why reaching it early helps.

No federal rule sets the one-day clock

We found no federal rule that says a possible kickback must reach Compliance in one business day. Companies write that deadline into their own procedures. Open Payments reports are due once a year.2

Many companies stopped asking for free text

From the mid-2000s, legal teams limited free-text fields in CRMs because notes could become evidence, by one CRM vendor's account. That vendor says the writing then moved to personal apps and email, which are harder to monitor.3

We found no published read rate

We found no public figure for the share of call notes that compliance teams read, or how long it takes. The 5% and six days in this guide's example are that example's estimates. Measure your own.

Four terms a call note reader needs: call note, remuneration, off-label, Open Payments

Call note

The free text a rep files after visiting a prescriber, typed in the CRM or dictated into its app.

Remuneration

The law's word for anything of value: money, a meal, a ticket, a paid course, a gift card.

Off-label

A use, dose, age group or patient type that the medicine's FDA-approved label does not cover.

Open Payments

The federal database, also called the Sunshine Act program, where drug and device makers report what they give to clinicians.

Fourteen terms are defined in the one-page summary.

02 · Five kinds of phrase

The five kinds of phrase a compliance reader hunts for in a post-call note

In shortField compliance teams read notes for five things: value offered in return for prescribing, gifts and meals outside policy, off-label questions, promotional language, and competitor or access remarks. Each goes somewhere different, and the fifth is useful business information that needs no compliance action.

A call note runs to a few sentences or a couple of minutes of speech, and one note can hold several of these. The example at the top of this page holds four: the dinner, a question about a 15-year-old, a comparison with a competing product, and a health plan's refusal. Teams use different labels. These five cover most of what commercial compliance policies list.

What to look forHow it sounds in a note (fictional)Who should get it
Value offered in return for prescribing (an inducement)"We can bring lunch for her whole staff every Friday once she has five patients on Veltrimab."Compliance investigators, quickly and with the facts
A gift or meal outside policy"I said I would drop off two tickets to Saturday's hockey game." "Her husband joined us for lunch."The team that keeps spend records, and Compliance
An off-label question"She asked whether she could double the dose for patients who flare."Medical Information, which answers in writing
Promotional language"I told her it works faster than anything else out there."A compliance reviewer, then coaching through the manager
Competitor and access remarks"Her biggest problem is the health plan, which makes patients try two other biologics first."The commercial team's field insights, with patients' names left out
In one fictional month, language flags outnumber possible inducements about eight to one

Findings needing a route in 27,940 sample call notes over 30 days. The rarest kind carries the highest risk, so counting alone misleads

Promotional language480
Off-label and medical questions389
Gifts and meals outside policy190
Possible inducements61

Fictional example from this guide

Show the numbers
Kind of findingFindings
Promotional language480
Off-label and medical questions389
Gifts and meals outside policy190
Possible inducements61

That shape, with the most serious finding as the smallest bar, explains why sampling is a poor fit. Pull 5% of notes at random and you would expect to see about three of those 61 offers. Which three would be luck.

03 · The rules and their status

Anti-Kickback, False Claims, Open Payments, FDA: the rules a call note touches, as of November 2026

In shortNo single law governs call notes. Four bodies of US law reach what a note records: the Anti-Kickback Statute, the False Claims Act, Open Payments and FDA's promotion rules. Over them sit voluntary codes and guidance from the federal health department's inspector general (OIG), PhRMA, which represents research drug companies, and the Justice Department (DOJ). We found no federal rule that requires a call note, or sets a deadline for reading one.

RuleWhat it does for this workStatus, November 2026
Anti-Kickback Statute, 42 U.S.C. 1320a-7b(b)Makes it a felony to knowingly and willfully offer or pay anything of value to induce a federally reimbursed purchase, order or recommendation: up to $100,000 and 10 years.1In force
False Claims ActUnder the kickback statute's subsection (g), claims "resulting from" a violation are false claims.1 Penalties run from $14,308 to $28,619 per claim, on top of damages, for penalties assessed after July 3, 2025.4 DOJ kept those levels for 2026.5In force. Courts split on causation (section 4)
Open Payments, 42 CFR Part 403Yearly reports of what manufacturers give covered clinicians, including meals. Due by the 90th day of the next year.2In force. 2026 thresholds $13.82 and $138.13; 2027 thresholds $14.31 and $143.016
FDA intended use, 21 CFR 201.128What a firm means a drug to be used for, its "intended use", can be shown by its "oral or written statements". Knowing that doctors prescribe off-label is not enough by itself.7In force
FDA advertising rule, 21 CFR 202.1Treats as false or misleading a comparison, or a claim of being safer or better, that substantial evidence does not support.8In force
FDA draft on unsolicited requestsRecommends that medical or scientific staff answer, with no input from sales.9Still a draft, from December 2011
FDA guidance on scientific information about unapproved usesCovers what a firm may share on its own initiative, kept separate from promotion.10Final, January 2025. FDA's page says not for current implementation, pending a paperwork decision by the Office of Management and Budget (OMB)
Sample rules, 21 CFR 203.31Signed request and signed receipt for each rep-delivered sample, with yearly inventory and reconciliation.11In force
OIG pharmaceutical guidanceVoluntary. Measures a compliance program in large part by its "commitment to training and monitoring its sales force".12OIG's newest pharma-specific text, May 5, 2003, now in its page's archive section. A new pharmaceutical guide is marked "publication date TBD". OIG's General Compliance Program Guidance of November 6, 2023 is listed as current13
OIG Special Fraud Alert on speaker programsLists warning signs: alcohol, meals beyond modest value, restaurant venues, repeat attendees, guests.14Issued November 16, 2020
PhRMA CodeVoluntary industry code. Reps' meals occasional, modest, in the office or hospital. No guests, no entertainment, no non-educational items.15Effective January 1, 2022
DOJ Evaluation of Corporate Compliance ProgramsWhat prosecutors ask about a program, including its data access and any AI it uses.16Updated September 2024
Six of these nine field compliance dates fall in 2025 or later

The dates that matter most to a field compliance program

  1. May 2003OIG pharma guidance

    Still OIG's newest pharma-specific text.

  2. Nov 2020Speaker program alert

    Warning signs for meals and attendees.

  3. Jan 2022PhRMA Code revision

    Stricter rules on meals and speakers.

  4. Jan 2025FDA final guidance

    Scientific information on unapproved uses.

  5. Feb 2025First Circuit, Regeneron

    A stricter causation test for one False Claims route.

  6. Sep 2025FDA letters surge

    Most of 74 letters in 2025 came from here on.

  7. Aug 2026Veloxis resolution

    What DOJ calls the largest Sunshine Act recovery.

  8. Sep 2026Zafirov vacated

    Whistleblower suits survive one challenge.

Source 12,13,14,15,10,17,18,19,20,21

Show the numbers
WhenWhat
May 2003OIG pharma guidance
Nov 2020Speaker program alert
Jan 2022PhRMA Code revision
Jan 2025FDA final guidance
Feb 2025First Circuit, Regeneron
Sep 2025FDA letters surge
Aug 2026Veloxis resolution
Sep 2026Zafirov vacated
Dec 2027EU AI Act high-risk rules

Which rule reaches which sentence in a call note

The kickback law and the False Claims Act reach offers; FDA's rules reach claims and questions

How directly each body of rules bears on each kind of phrase

LittleSomeDirect
Offer tied to prescribingGift or mealOff-label questionPromotional claimAnti-Kickback StatuteDirectSomeLittleLittleFalse Claims ActDirectSomeSomeLittleOpen PaymentsSomeDirectLittleLittleFDA promotion rulesLittleLittleDirectDirectPhRMA CodeDirectDirectLittleLittle

Our reading of the sources 1,14,15,22,9,7,8

Show the numbers
Offer tied to prescribingGift or mealOff-label questionPromotional claim
Anti-Kickback StatuteDirectSomeLittleLittle
False Claims ActDirectSomeSomeLittle
Open PaymentsSomeDirectLittleLittle
FDA promotion rulesLittleLittleDirectDirect
PhRMA CodeDirectDirectLittleLittle

States add their own layer. Vermont bars most gifts to health care providers, food included, with a civil penalty of up to $10,000 for each violation.23 Minnesota bars gifts to practitioners, leaving out items worth $50 or less in total in a calendar year.24 Other states have their own rules. Companies outside the US work under different national laws and industry codes. Apart from the EU AI rules in section 11, this guide covers the US. Have counsel list what applies to your field force.

04 · When an offer is a problem

How a rep's offer becomes a kickback question: one purpose, four facts, no payment needed

In shortThe statute covers offering as well as paying, and OIG's guidance says an arrangement is in play if any one purpose is to generate business. So the words of the offer matter more than its price. Investigators need four facts: who offered, to whom, what of value, and in return for what.

The Anti-Kickback Statute has three features a newcomer should know. It covers whoever "offers or pays" remuneration.1 It does not require that the person knew about this statute or specifically meant to break it.1 And OIG reads it widely: arrangements such as meals, gifts and entertainment "potentially implicate" it "if any one purpose of the arrangement is to generate business".12 OIG adds that the outcome depends on the facts, and that following the PhRMA Code "should substantially reduce" a company's risk.12

Words in a note cannot prove a crime. They can show that someone needs to look. A note saying a dinner depends on three new patients states a condition. A note saying a dinner took place after an educational talk does not. Those sentences need different handling, even when they share most of their words.

Three fictional sentences, three different answers

What the note saysThe four factsA sensible route
"Cobbleford would sponsor a dinner for her whole practice once she moves her next three new psoriasis patients onto Veltrimab."Rep · Dr. Ruiz and practice · a dinner · three new patients. All four present.Investigators. Value tied to prescribing, even though nothing is booked.
"He asked whether Cobbleford could pay for his nurse to attend the national course; I told him only the independent grants office decides that."Physician asked · nurse · a paid course · nothing asked in return.A person checks, and it probably closes. The rep answered correctly.
"Lunch was from a local caterer for eight people, and I paid on my own card because the corporate card was declined."Rep · attendees · lunch · amount missing.Spend team. Ask the rep for the amount and the attendee list, then log it.

Why a modest meal is taken seriously

A $20 lunch sounds trivial, and compliance teams still take it seriously. Research on Medicare prescribing suggests why. A 2016 study of 279,669 physicians found that 95% of the payments tied to four promoted drugs were meals, with a mean value under $20. Physicians who received a single such meal had higher relative rates of prescribing the promoted drug.25 The study is cross-sectional: it shows an association and cannot show that the meal caused the prescribing.

One meal under $20 went with higher odds of prescribing all four promoted drugs

Odds ratio (2.0 means double the odds) of prescribing the promoted drug over others in its class, physicians with one sponsored meal against those with none. Association only, 2013 data

Desvenlafaxine (SSRIs and SNRIs)2.18
Nebivolol (beta blockers)1.7
Olmesartan (ACE inhibitors and ARBs)1.52
Rosuvastatin (statins)1.18

Source 25

Show the numbers
Promoted drugOdds ratio
Desvenlafaxine (SSRIs and SNRIs)2.18
Nebivolol (beta blockers)1.7
Olmesartan (ACE inhibitors and ARBs)1.52
Rosuvastatin (statins)1.18

Causation and whistleblower suits: what the courts are still arguing about

Two live disputes affect how much a kickback case can cost, and neither makes an offer acceptable. Check the status of both with counsel before relying on either.

Causation

How directly a kickback must lead to a claim

In February 2025 the First Circuit, a federal appeals court, held in Regeneron that when the government relies on the "resulting from" language, it must show the kickback was the but-for cause of the claim: the claim would not have been made without it. The Sixth and Eighth Circuits agree, while the Third asks only for a link. The same opinion leaves another route, false certification, open without that showing.17

Whistleblowers

Whether private whistleblower suits are constitutional

On September 1, 2026, the Eleventh Circuit vacated the Florida ruling in Zafirov that had said they were not. It held that whistleblowers fall outside the Appointments Clause, the Constitution's rule on how federal officers are chosen, and sent the other constitutional arguments back to the district court.20

05 · Meals and Open Payments

Meals, gift cards and hockey tickets: the Open Payments arithmetic behind a line in a note

In shortA meal is reported per person, split among everyone who ate, staff included, and shown only for covered clinicians who ate. Under $13.82 it may drop out, unless that clinician passes $138.13 for the year. So a note that names who was at lunch feeds a federal report, and a missing name makes that report wrong.

Open Payments requires manufacturers to report transfers of value to covered recipients: physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and anesthesiologist assistants, certified nurse-midwives and teaching hospitals.26 For a shared meal, the rule says to divide the cost by everyone who ate, including "non-covered recipients, such as office staff", and to report only for covered recipients who actually ate.22

Working out one catered lunch

Take the catered lunch from the third example in section 4 and add a figure, since the note gives none. Suppose the food cost $184, for eight people: the physician, Dr. Fischer; two nurses; others from the office; and two guests.

StepIllustrative workingWhy it matters
Cost per person$184 ÷ 8 who ate = $23.00The divisor counts everyone who ate, so the attendee list matters
Who gets a lineDr. Fischer, $23.00. A registered nurse is not on the covered list unless she also holds one of its titlesEach covered clinician who ate gets a record22,26
Threshold, 2026$23.00 is above the $13.82 small-payment amount6Reportable, whatever else she receives this year
Below the small amountA $10 coffee is excluded, until her total for the year passes $138.136Past that total, all of them must be reported, so someone has to keep count
The deadline2026 payments are due by the 90th day of 20272A yearly duty. A one-day logging rule is a company's own choice

The $184 is our assumption, for the arithmetic only. The sample note gives no amount, which is why the rep would be asked.

How an expense report can quietly shrink a meal

In its August 2026 resolution, the drug maker Veloxis admitted that employees falsified expense reports by adding names to attendee lists, which lowered the apparent cost per attendee, and by leaving out clinicians who did attend.27 Its reports to the Centers for Medicare & Medicaid Services (CMS), the agency that runs Open Payments, drew on those records and understated the payments, which led to the $1.55 million civil penalty.28,19 A note that says who ate and an expense report that lists attendees can check each other, so read them together.

Adding four names to a $600 dinner cuts the reported cost per person in half

The same bill, divided by those who ate and by a padded attendee list. Our arithmetic, to show the method Veloxis admitted

Four who ate$150
Eight names on the report$75

Illustrative · replace with your own numbers

Show the numbers
Attendee listReported per person
Four who ate$150
Eight names on the report$75

Open Payments reports a meal; the PhRMA Code and company policy limit it

QuestionFederal Open PaymentsPhRMA Code (voluntary)Company policy (fictional example)
Dollar limitNone. It reports"Modest as judged by local standards"15$140 a person
WhereNot addressedReps' meals: in the office or hospital15With an educational presentation
GuestsThey count in the divisor if they ate22"Not appropriate"15Never spouses or guests
Tickets and gift cardsReported if givenNot to be offered, "regardless of" value (entertainment)15Never allowed
When loggedYearly report2Not addressedOne business day

How much money runs through the Open Payments database

Reported payments reached $14.67 billion in program year 2025

Total published value of payments and transfers by program year, in billions of dollars. Figures change as records are refreshed

11.12018
122019
10.62020
12.62021
13.12022
13.12023
13.22024
14.72025

Source 29,30

Show the numbers
Program year$ billions
201811.1
201912
202010.6
202112.6
202213.1
202313.1
202413.2
202514.7
Research is most of the money; general payments, meals among them, are $3.92 billion

Program year 2025, $14.67 billion across 17.07 million records

Research: $9.5BGeneral payments: $3.9BOwnership and investment: $1.2B
$14.67B2025
  • Research$9.5B
  • General payments$3.9B
  • Ownership and investment$1.2B

Source 29

Show the numbers
PartValue
Research$9.5B
General payments$3.9B
Ownership and investment$1.2B

CMS's own penalties are rare. In fiscal 2025 it sent 9 warning letters, completed 4 audits and issued no Open Payments penalties, with a decision on one audit pending.30 The rule sets $1,000 to $10,000 per unreported item, and $10,000 to $100,000 if the failure is knowing, adjusted for inflation.31 At the 2025 levels those ranges are $1,443 to $14,432 and $14,432 to $144,329.32 OMB canceled the 2026 adjustment for agencies.5 Veloxis's recovery came through the Justice Department.19

06 · Off-label questions

Off-label requests in call notes: who may answer, and what turns a question into a solicited one

In shortDoctors may ask about unapproved uses, and the company may answer through its medical team. FDA's draft guidance calls a question unsolicited when the rep did nothing to prompt it. A rep who mentions the use and invites a request makes the follow-up solicited, and it can then be evidence of intended use. So a note's order of events matters.

Off-label means outside the approved label: another disease, another age, another dose. Physicians often have good reason to ask. Companies must be careful about how they respond, because under 21 CFR 201.128 a firm's intended use can be shown by "oral or written statements", while its mere knowledge that doctors prescribe a drug off-label does not establish intent.7 So a rep's words can count as evidence of the firm's intent. A doctor's off-label prescribing, by itself, does not.

FDA's 2011 draft sets out how a firm should respond to a private question from one doctor. It recommends referring the question to the firm's medical or scientific department, keeping the answer non-promotional, and giving sales and marketing staff "no input" on its content. It also lists what to keep on record: the nature of the request, who asked, what was sent and any follow-up.9

This text is still a draft, so treat it as FDA's current thinking. Under a procedure built on it, the rep's job is simple to state: decline, offer the medical team, and write down what happened.

The same question, handled two ways

Dr. Ruiz, 15-year-old patient (fictional)
She asked
Can I start Veltrimab in a 15-year-old?
The rep said
"I can't discuss that, but Medical Information can send a written answer."
Route
Medical Information request. No coaching
Dr. Ferreira, an unapproved condition (fictional)
He asked
Can I use Veltrimab for this patient's condition?
The rep said
"Some doctors have seen good results with it and it might help."
Route
Medical Information, plus a compliance decision on the rep

FDA's draft also gives the reverse case, which reviewers look for: if a sales representative mentions an unlabeled use and invites a professional to ask for more, any resulting request counts as solicited.9 A note that reads "I mentioned the data in teens and she asked for it" is a different event from one that reads "she asked about teens", even though both end in a request.

The January 2025 guidance covers something separate: scientific information a firm chooses to share on its own initiative. In an in-person visit, FDA says, it should stay apart from promotional communications, and those who share it should have specialized training, or know how to direct questions to medical or scientific staff.10 FDA's page says the guidance is not for current implementation until OMB decides on its information collection.10 Your policy should say who, if anyone, in the field may do it.

What whistleblower complaints say off-label programs looked like

The best public picture comes from a 2011 study of 41 unsealed whistleblower complaints from 18 cases, which led to $7.9 billion in recoveries. These are allegations, and they are old, but the patterns still match what compliance teams look for.33

Unapproved diseases were the commonest off-label goal, and doses appeared in a third of complaints

Share of 41 whistleblower complaints, 1996 to 2010, alleging each goal. A complaint can allege several

Unapproved diseases85%
Unapproved disease subtypes54%
Unapproved doses34%

Source 33

Show the numbers
Alleged goalShare of complaints
Unapproved diseases85%
Unapproved disease subtypes54%
Unapproved doses34%
Direct financial incentives to physicians appeared in 85% of off-label complaints

Share of the same 41 complaints alleging each practice aimed at prescribers. Off-label promotion and offers of value often travel together

Direct financial incentives85%
Self-serving presentation of the literature76%
Teaching activities54%
Free samples20%
Research activities20%

Source 33

Show the numbers
Alleged practiceShare of complaints
Direct financial incentives85%
Self-serving presentation of the literature76%
Teaching activities54%
Free samples20%
Research activities20%

The second chart is a reason to read for both kinds of phrase in the same pass. An offer and an off-label question in one note, as in this guide's example, is a pattern with history behind it.

07 · Promotional language

"Works faster than anything else": promotional claims a rep can make out loud, and FDA's 2025 letters

In shortWhat a rep says to a doctor counts as promotion. FDA's rules treat unsupported comparisons and overstated claims as misleading, and its promotion office lists sales representative presentations among what it regulates. FDA sent 74 letters to drug and biologic makers in 2025, nearly all from September 9 on, most of them about TV ads.

FDA's Bad Ad program tells clinicians how to report misleading promotion, anonymously if they wish, and it lists "Sales representative presentations" alongside television ads and printed pieces.34 The advertising rule says a promotion is false or misleading if it claims a drug is better or safer than another without substantial evidence, or safer than has been demonstrated.8 That gives a compliance reviewer three questions about any sentence: does it make an absolute claim, does it compare without head-to-head evidence, and does it say more than the label?

Kind of claimWhat the rep said (fictional)The problemWhat an approved line sounds like
Comparison"Clears skin faster than Zorelta."No head-to-head study in the label or approved material"At Week 16, 74% of patients on Veltrimab achieved clear or almost clear skin, versus 6% on placebo."
Absolute"Totally safe, and no lab tests are ever needed."Contradicts the label's testing instruction"Before starting Veltrimab, patients are evaluated for TB. I can walk you through the label."
Beyond the label"Patients see itch relief by the first night."Says more than the label's reported timingThe timing the label states, quoted from approved material
Overreach"Basically a steroid-free cure."A cure claim the label does not makeThe approved description of what the medicine does

What FDA's 2025 letters tell a field compliance team

One law firm counted 74 letters to pharmaceutical and biologic manufacturers in 2025, 10 Warning Letters and 64 Untitled Letters, FDA's two kinds of enforcement letter. That was the highest annual total in nearly 25 years. Only five came before September 9, 2025. Most concerned consumer television ads, and 16 challenged promotion aimed at health care professionals. Benefit claims cited included overstated efficacy and unsubstantiated superiority.18 We found no equivalent public count for 2026.

Forty-two of FDA's 74 promotion letters in 2025 targeted TV ads; 16 concerned promotion to professionals

Two counts from the 74 letters to drug and biologic manufacturers, by a law firm. The rest went to other media, and the firm does not say whether the two groups overlap

Consumer TV ads42
Promotion to professionals16

Source 18

Show the numbers
What the letters targetedLetters
Consumer TV ads42
Promotion to professionals16
Five letters came before September 9, 2025, and 69 from that date on

The same 74 letters, by date. The firm reports the five; 69 is the remainder

January 1 to September 85
September 9 to December 3169

Source 18

Show the numbers
When issuedLetters
January 1 to September 85
September 9 to December 3169

These letters mostly concern ads and printed material. A spoken claim leaves little trace except a rep's own note, which is one reason compliance teams want to read those notes, and coach from the actual words.

08 · Why word lists miss

Keyword lists against plain-word offers: what call note review misses and flags in error

In shortA phrase list finds what someone thought to list. Real offers use ordinary words, and real false alarms come from words that are harmless where they stand. Reading for meaning changes both errors, and it brings new ones you must measure. No public benchmark exists, so test any method on your own notes.

The common first tool is a list of phrases. One CRM vendor's documentation shows the idea: compliance users choose the free-text fields to watch and the phrases to flag, with "save money" as its example, and then review the notes that match.35 This is cheap and simple to explain, and it does catch the words on the list. It has two blind spots, and tuning the list trades one for the other.

Misses

Offers in plain words

"Sponsor a dinner for her whole practice once she moves her next three new psoriasis patients" contains nothing a sensible list would ban. Dinner, practice and patients are everyday words in a note.

False alarms

Words in the wrong place

List "pediatric" to catch off-label talk about children, and you flag every note about Aldervale Pediatric & Adult Dermatology, because it is in the practice's name.

Tuning

Add words, add noise

A longer list can catch more and flag more. Each false alarm takes a reviewer's time and teaches the habit of clearing hits quickly, the habit you least want when a real one arrives.

A word list caught about 15 in every 100 possible inducements in one fictional month
9 of 61

possible inducements caught by the keyword list in 30 days of sample notes, about 15 in 100

Fictional example from this guide

Show the numbers
MeasureValue
possible inducements caught by the keyword list in 30 days of sample notes, about 15 in 10015 of 100
In the example, reading for meaning finds more of every kind, and far fewer false alarms

Sample month, 27,940 notes. Every figure comes from this guide's fictional example and needs testing on your own notes

Keyword listReading for meaning
Possible inducements found961
Gifts and meals found74190
Off-label questions found142389
Language issues found301480
False alarms to clear1,21238

Fictional example from this guide

Show the numbers
Keyword listReading for meaning
Possible inducements found961
Gifts and meals found74190
Off-label questions found142389
Language issues found301480
False alarms to clear1,21238

A caution on those numbers: nobody can count what no one found. In a sample month, "61" means what the better reader found, so the keyword list's 9 is measured against that reader. A reader for meaning makes its own mistakes: it can read intent into a joke, or miss an offer told in shorthand.

We found no published recall (the share of real issues found) or false-alarm figure for any method on real call notes. Vendors publish descriptions: one 2026 guide from a CRM vendor says large language models now read free text with a consistency and speed impractical for human reviewers, and screens notes as they enter the system, but it gives no test results.3 A 2026 article promoting a review tool has no figures either.36 Ask each vendor for its numbers on your notes.

09 · What settlements show

What field conduct has cost drug makers: Veloxis, Gilead, Biohaven, Medtronic and a record False Claims year

In shortRecent settlements turn on meals, trips, guests and speaking fees, and three of the four below began with a whistleblower suit. The Justice Department reported more than $6.8 billion in False Claims Act recoveries for fiscal 2025 and 1,297 whistleblower suits, both records. Employees' own messages and records can become the evidence.

MatterWhat it resolvedWhy it matters to a note reader
Veloxis, August 2026More than $46 million in all. The company admitted meals above its limits, resort stays with spouses, gifts, alcohol and consulting payments. A three-year deferred prosecution agreement, which the Justice Department calls a middle ground between dropping a case and a conviction, and a five-year integrity agreement.19Messages between employees and clinicians linked payments to prescribing. Expense reports were falsified. The civil case began with a whistleblower suit filed in 2020.28
Gilead, April 2025$202 million over HIV speaker programs from 2011 to 2017. Prosecutors cited over $20 million in speaking fees and millions more on meals, alcohol and travel. Gilead said it settled to avoid the cost of litigation.37A practicing physician brought the suit in 2016. A whistleblower's suit can stay secret, under seal, for years.
Pfizer for Biohaven, January 2025$59.7 million. Allegations include repeat attendance, guests, costly meals and lunch visits with little education. Biohaven denies them.38The whistleblower was a former sales representative.
Medtronic, October 2020$9.2 million, with $1.11 million for Open Payments reporting. Allegations cover more than 130 events at a restaurant a surgeon owned. No admission of liability.39Sales staff allegedly kept facts from compliance. The company fired those involved and disciplined 12 others.
Four recent field conduct matters ran from $9.2 million to $202 million

Total amount of each resolution. Veloxis is more than $46 million. Only Veloxis includes admissions; the others are allegations

Gilead, 2025$202M
Pfizer for Biohaven, 2025$59.7M
Veloxis, 2026$46M
Medtronic, 2020$9.2M

Source 19,37,38,39

Show the numbers
MatterAmount
Gilead, 2025$202M
Pfizer for Biohaven, 2025$59.7M
Veloxis, 2026$46M
Medtronic, 2020$9.2M
Whistleblowers filed 1,297 False Claims suits in fiscal 2025, up from 980

Qui tam (whistleblower) lawsuits filed, all industries, fiscal years ending September 30

9802024
1,2972025

Source 40

Show the numbers
Fiscal yearSuits filed
2024980
20251,297

Fiscal 2025 recoveries topped $6.8 billion, the most in the False Claims Act's history, and over $5.7 billion of that involved health care.40 These totals cover many kinds of matter, far beyond sales conduct.

For the long view, Public Citizen counted 412 pharmaceutical settlements worth $38.6 billion from 1991 to 2017. It also found that penalties for unlawful promotion fell 94%, from $8.7 billion in 2012 to 2013 to $527 million in 2016 to 2017.41 That count ends in 2017. The four matters above, all later, turn on meals, speakers and payments.

10 · Monitoring duties

What a corporate integrity agreement asks of a field force monitoring program

In shortA drug maker that settles a federal fraud case may also sign a Corporate Integrity Agreement. These spell out monitoring in detail, and the two read for this guide name call notes. OIG's 2003 guidance and DOJ's 2024 questions ask for similar things in general terms. So a company without such an agreement can still read what one requires as a guide to good practice.

A Corporate Integrity Agreement, or CIA, is a multi-year contract with the federal health department's inspector general (OIG). Its monitoring sections are the most concrete public description of this work. The agreement Veloxis signed in August 2026 calls for a Field Force Monitoring Program "to identify potential inappropriate promotional activities or other improper conduct", in two parts.42 Endo's 2014 agreement used similar language, with call notes on its list.43

Observations

Full-day ride-alongs

Monitors shadow a rep through a whole working day. At least 20 observations, or 15% of the field force, whichever is larger, in each reporting period. A report follows each one.42

Records Reviews

What the reps' records show

A yearly plan covering at least two products and every district or region. The list includes meal, sample and expense records, medical information requests, "field personnel call notes", emails and texts, and managers' notes.42

Results go to the Compliance Officer. A probable violation becomes a Reportable Event, which the company must report to OIG in writing within 30 days of determining that it exists.42 That clock runs from the company's determination and applies under the agreement. It says nothing about how soon a company must find out, which is the gap a monitoring program is there to close.

For a sense of scale, take this guide's fictional field force of 612 reps: 15% is 92 full-day ride-alongs a period. The records review leaves more choice of method. In 2003 OIG said a commitment to compliance "can be measured by" a company's "commitment to training and monitoring its sales force".12 DOJ asks whether compliance staff can reach the data they need, and whether technology given to compliance matches technology given to sales.16

Here is what a 5% sample leaves unread in this guide's fictional month.

At a 5% sample, 26,543 of 27,940 notes in one month are never read

The example's own estimate of sampling. No public figure exists for your industry; count your own

Notes filed in 30 days27,940
Notes in a 5% review sample1,397

Fictional example from this guide

Show the numbers
StageCount
Notes filed in 30 days27,940
Notes in a 5% review sample1,397
11 · Speech, AI and the limits

Voice notes and AI review: what transcription gets wrong, and which AI rules actually apply

In shortSoftware can read every note, and that changes coverage more than judgment. Speech tools mishear, unevenly across speakers. Most pharma AI rules do not cover this work, because it is a commercial compliance task, while DOJ's questions and, in Europe, the AI Act's worker-monitoring rules do apply. A person decides every case.

Automation changes one thing outright: reading every note stops being an expensive idea. It does not change who decides. Intent, context and fairness to a named employee need a person, a point even the promoters of review software make: strong programs "intentionally combine AI-driven detection with expert review and decision-making".36

What speech recognition gets wrong

Dictated notes depend on a transcript, and a transcript can be wrong in ways that matter when the text may lead to a case against a person. A study run in 2023 and presented in 2024 found that roughly 1% of one speech tool's transcriptions, on clips that included people with aphasia, a condition that limits speech, held whole invented phrases. Its lead author says the tool has since improved.44 A 2020 study of five commercial systems found an average word error rate of 0.35 for Black speakers and 0.19 for white speakers.45

Both are older than today's tools and neither tested call notes, so treat them as reasons to test. Keep the audio beside the transcript, have a person listen before any case opens, and compare error rates across your own reps.

Five commercial speech systems made nearly twice the errors for Black speakers in a 2020 study

Average word error rate: 0.35 means about 35 words wrong in 100. 19.8 hours of interviews, 115 speakers

Black speakers0.35
White speakers0.19

Source 45

Show the numbers
SpeakersWord error rate
Black speakers0.35
White speakers0.19

Which AI rules reach a call note reader

Rule or guidanceDoes it apply?Status
DOJ Evaluation of Corporate Compliance ProgramsYes, as questions prosecutors ask. "What baseline of human decision-making is used to assess AI?" and how the company measures "the accuracy, precision, or recall" of its models16Updated September 2024
EU AI Act, Annex III point 4(b)Yes, if you use it on EU workers. AI used to monitor and evaluate workers' performance and behavior is listed as high-risk46Applies from December 2, 2027 under the AI Omnibus, Regulation (EU) 2026/174421
EU AI Act, Article 5(1)(f)It bars inferring emotions at work from biometric data, so read a voice note's words and never its tone47In effect since February 2, 202521
US employee monitoring lawsSome states require notice. New York requires written notice of monitoring of phone, email and internet use48In force. Check each state with counsel
FDA draft on AI for regulatory decisionsGenerally no. It concerns regulatory decisions on drugs and leaves out "operational efficiencies" that do not affect patients, quality or study results49Draft, January 2025
Draft EU GMP Annex 22, revised Annex 11No. Both concern manufacturing systems under good manufacturing practice (GMP). Draft Annex 22 says generative AI and large language models should not be used in critical GMP applications, a scope call notes fall outside50Still drafts. The EU's published GMP rules (EudraLex) list no Annex 2251
A missed offer and a wrong accusation are the two errors worth testing hardest

Our judgment of how often each error is likely and how much harm it does. Replace it with your own test results

Harm if it happens →
Test hardest
Test and monitor
Accept and sample
Tune away
Missed offerWrong accusationMisheard drug namePractice name false alarmClaim wrongly graded
How often it is likely →

Illustrative · replace with your own numbers

Show the numbers
ItemHow often it is likely (0–1)Harm if it happens (0–1)
Missed offer0.250.80
Wrong accusation0.300.65
Misheard drug name0.550.56
Practice name false alarm0.750.10
Claim wrongly graded0.550.25

Treat any claim that such a tool is certified with suspicion. GxP (the good-practice rules for regulated manufacturing, laboratory and clinical work) and 21 CFR Part 11 (FDA's rule on electronic records and signatures) cannot be certified for a product, and a vendor can only offer controls that support your own compliance. Sample records under 21 CFR 203 have their own rules.11 Ask instead what is logged, who can change it and how you would show it to an examiner.

12 · How teams do it today

Samples, word lists and a monthly review: how field compliance teams read call notes now

In shortA small compliance team pulls a sample, reads it weeks later, chases the rep or the manager for missing facts, and refers what it finds. The longest single wait comes before anyone reads. Four ways of working exist, and many companies combine them.

From rep to investigator: who handles a call note

SR

Sales representative

Files the note, often by voice, usually without knowing which words matter.

Cares about: not guessing where the line is.
DM

District manager

Coaches reps, rides along, sees their numbers.

Cares about: the exact sentence and an approved line to offer in its place.
FC

Field compliance lead

Runs the monitoring, decides what goes where.

Cares about: the sentence, the rule and the deadline, in one view.
CI

Compliance investigator

Opens and runs cases. Often works with legal.

Cares about: when it happened, and who was there.
MI

Medical Information

Answers unsolicited questions in writing.

Cares about: the doctor's question as asked, and whether the rep answered it first.
ST

Spend and transparency team

Keeps meal and gift records for Open Payments and state reports.

Cares about: names, amounts and receipts.
A sampled note takes five steps to reach an investigator

A typical manual path. Roles and order vary by company

  1. 1Note filed

    Typed or dictated into the CRM.

    Sales representativeAfter the call
  2. 2Picked for review

    A sample, a phrase match or a manager's referral.

    Field complianceOften weeks later
  3. 3Read and judged

    Someone recognizes the offer.

    Field complianceMinutes per note
  4. 4Facts gathered

    Who, what, how much, who else was there.

    Compliance, rep, managerDays of messages
  5. 5Referred

    Case opened, or coaching sent.

    Investigator or managerAfter all of the above

Our reading of the sources 42,43,35

Show the numbers
StepWhat happensWhoTime
Note filedTyped or dictated into the CRM.Sales representativeAfter the call
Picked for reviewA sample, a phrase match or a manager's referral.Field complianceOften weeks later
Read and judgedSomeone recognizes the offer.Field complianceMinutes per note
Facts gatheredWho, what, how much, who else was there.Compliance, rep, managerDays of messages
ReferredCase opened, or coaching sent.Investigator or managerAfter all of the above
Half of one offer's six days goes on waiting to be picked for a sample

Estimated days from the call to Compliance for one offer of value, sampled review. This is the example's estimate; time five of your own

Note written and filedWaiting for the sampleRead and recognizedGathering factsSending to Compliance
One offer, about six days3 days1 day1 day

Illustrative · replace with your own numbers

Show the numbers
Note written and filedWaiting for the sampleRead and recognizedGathering factsSending to Compliance
One offer, about six days0.5 days3 days1 day1 day0.5 days

Sample in house, list in the CRM, review software or outside reviewers: four ways to monitor call notes

WayWhat it looks likeWhere it strains
Sampled reading in houseA monitor exports notes each month and reads a sample against a checklistMost notes go unread. The reading happens long after the visit
Phrase rules in the CRMListed phrases are flagged, and a compliance user reviews each match35Plain-word offers pass. Reps can learn to avoid the listed words
Software that reads for meaningText checked at entry or read in bulk, with people deciding3,36Needs testing, a record of each decision, notice to employees, and a plan for what the output is for
Outside reviewersA consultancy or independent reviewer samples records, often during a CIA42,19Strong on independence, slow by design. Does little for an offer made yesterday

Why many drug makers limited free-text call notes, and why that is being reopened

Not every company has free-text notes to read. A CRM vendor's March 2026 guide for legal teams says that from the mid-2000s, legal and compliance leaders limited free-text fields because notes "could be used as evidence" in enforcement and litigation, and because fewer free-text records meant fewer to review. It says the result was notes kept in personal apps, calendars and email, which remain discoverable and are harder to monitor.3

The vendor sells a tool for this, so weigh its account accordingly. We found no published count of how many companies allow free text. The choice belongs to your legal team, and it now turns on whether you can read everything that gets written.

Part B · See it working

Botminds Call Note Compliance Monitoring on one morning of notes at a fictional biotech

Part A described the work without naming a product. This part shows how Botminds does it, for a fictional company, Cobbleford Pharma, with 612 reps and three products. Every person, note, policy, label passage and number on these screens is sample data, including the one-business-day clock and the $140 meal limit, which are that company's own sample policies and quote no regulator.

13 · A dinner offer, in the reader

Sam Patel's dinner offer: from one highlighted sentence to a case in front of the investigators

In shortThis is the example from the top of the page, inside the product. Agents read every note, overnight or as it arrives. Lena Ortiz, the field compliance lead, opens Sam Patel's voice note on the morning of October 7 and sees the dinner highlighted, the four facts filled in and 4 hours 15 minutes left. She decides where each finding goes.

1

Every note read before anyone starts work

The nightly run finished at 2:41 a.m., and notes filed after it, such as Sam's at 8:05 a.m., are read as they arrive. The list counts 1,284 of 1,284 notes read, typed and spoken. Each row shows what the agents found, its stage and the clock from the call. Findings sort to the top, with the nearest deadline first.

Lena does not choose a sample. Ten notes need her decision today.

Every call note. Typed and spoken notes, with what was found in each, the stage and the clock. Lena filters by route, product or region.
2

The note itself is the screen

CN-40817 is Sam's 1:48 voice note about Dr. Elena Ruiz in Denver. Each phrase that matters is marked in the rep's own words, in its color: red for a possible inducement, violet for an off-label request, amber for promotional language, blue for competitor and access remarks.

One click on a highlight opens its finding on the right. The words are never changed. Sentence numbers tie each finding to its source.

The call note reader. Highlights inline in the note, the audio above it, and the finding beside it. The escalation shows 97% confidence and the case's four facts.
3

The clock runs from the call

The call was Tuesday at 2:20 p.m. The note was filed Wednesday at 8:05 a.m., 17 hours and 45 minutes later. Under this sample company's procedure the deadline is a business day from the call, so it falls at 2:20 p.m. Wednesday, whatever time the note came in. At 10:05 a.m., 4 hours and 15 minutes remain.

Offered by, offered to, what of value, in return for: four of four, each cited to the call report or to a sentence. Had one been missing, the agents would have drafted a question to Sam for Lena to send.

Clock and four facts. Call, filing and deadline side by side, with the route to investigators waiting for a person.
4

The old keyword list, on the same note

One button runs the comparison. The list missed the dinner, because no listed word is in the sentence. It also missed the 15-year-old question and the comparative claim, and flagged "pediatric" in the practice's name, Aldervale Pediatric & Adult Dermatology.

This helps at a pilot, when someone asks what the old method would have done with your own notes.

Agents and the keyword list. One note, both methods: what each caught, missed or flagged in error.
5

The 15-year-old question goes to Medical Information

Dr. Ruiz asked, unprompted, whether she could start Veltrimab in a 15-year-old. The agents mark the request as unsolicited, citing sentence 5, and mark Sam's reply as correct, citing sentence 6. They set the physician's question out as the request will read, with the sample label passages.

Omar Haddad's Medical Information team answers in writing, by email, as Dr. Ruiz agreed. Sam needs no coaching for this one.

Medical Information request. Unsolicited, handled correctly, ready to send. The label text is the sample product's. Two business days is the sample company's target.
6

A comparative claim, with the approved line beside it

Sam said Veltrimab "clears skin faster than Zorelta". The agents find no head-to-head study in the label or approved material, cite the sample company's promotional standard, and offer the approved sentence from the company's sales material, its detail aid. They also note that this is Sam's second language flag in 30 days.

Lena chooses to coach, escalate or dismiss. Dismissing needs a reason. Coaching goes to Sam's district manager, Priya Ranvelle, with the sentence, the rule and the approved line.

Compliance review. The sentence, why it fails, and an alternative quoted from approved material. The agents never write a new claim.
14 · A voice note as it arrives

Weekly staff lunches for five patients: a 38-second voice note read as it is transcribed

In shortAt 10:04 a.m., a new voice note arrives from Jordan Lee in Atlanta. As the words appear, an offer turns red and the clock starts from the 9:15 a.m. call. Five agents finish in 4.1 seconds on the sample note. Lena sends the case to the investigators two minutes after it arrives, with 23 hours and 9 minutes to spare.

1

A note waits at the top of the list

Jordan Lee called on Dr. Nia Robinson at Copperleaf Skin & Laser at 9:15 a.m. and dictated a note 49 minutes later. It sits at the top of the list, marked New. Nothing has been found yet, and no clock is running. If the note holds value offered to a prescriber, the clock will start from the call rather than from now.

A voice note arrives. The call report comes from the CRM. The panel on the right explains when a clock would start.
2

The clock starts when the words appear

Fifteen seconds in, the transcript reaches "bring lunch for her whole staff every Friday once she has five patients on Veltrimab". The phrase turns red and the four facts fill in. The clock starts at 23 hours 10 minutes, counted from the call, and the route to investigators appears.

Nothing goes anywhere yet. The panel says so: nothing is sent without you.

Reading along. The highlight, the clock and the facts arrive as the sentence does, each agent's step listed below the transcript.
3

The whole note, read

The other findings follow: "double the dose for patients who flare" as an off-label question, "still start on Zorelta because of its copay card" as a competitor mention, and "works faster than anything else out there" as promotional language. The note records no reply to the dose question, so that finding shows the rep's response as not recorded.

All findings in one note. Four kinds of finding, 96% confidence on the offer, and how the agents read it below.
4

Lena sends it; the case carries the call date

At 10:06 a.m., Lena presses Send to Compliance investigations. Case CI-26-0440 opens with the call date carried over, her name and the time on record. That night's reconciliation will confirm the case exists and the date matches. The off-label question and the promotional language wait for her decision.

Sent to the investigators. Who, when, the case number and the call date. The route now shows the case as received.
15 · Meals, referrals, reps, insights

A lunch on a personal card, referrals by destination, nudges for the rep and what doctors say about access

In shortThe other screens follow one note's findings to their destinations, show the rep what will go to Compliance before submitting, and turn the rest of the notes into de-identified insights. A dashboard reports coverage and speed, and settings hold your own rules.

A gift or meal referral with one fact missing

Gift or meal referral. Derek Owens paid for a lunch on his own card, and guests ate without signing in. Three of four facts are present, so the rep has been asked for the amount. Under this company's sample procedure, 25 minutes remain. The case for an accurate Open Payments record, from section 5, starts here.

The keyword list, side by side, across every note

Old keyword list column. One toggle adds what the list did with each note: missed the personal card, caught "pay for", missed the dinner.
Agents and the list over 30 days. Sample data: 61 against 9 possible inducements, 38 against 1,212 false alarms. Section 8 explains how to read these.

Referrals by destination, reconciled every night

Referrals. One board by destination. The strip on top counts what was sent this month, what was acknowledged, what is unmatched and what went late, so a referral cannot slip between systems unnoticed.

What the rep sees while dictating

The rep's view. Before submitting, the rep sees what will go to Compliance and the approved line for an absolute claim. Nothing leaves the CRM until submit. If the rep keeps the original words, Compliance reviews them.

Access barriers and competitor remarks, with patients' details left out

Field insights. What physicians told reps yesterday, de-identified, each linked to its sentence. Health plan barriers and competitor activity sit in the same notes as the risks.

Coverage and speed on one dashboard, and rules in your own terms

Dashboard. Thirty days of sample data, by region and kind. "Before" figures on it are estimates.
Your rules. When the clock starts, the deadline, what is logged automatically and what the agents look for. Every change is versioned on the audit trail. The $140 is the sample company's limit.

Design targets for hours from the call to Compliance

These are design targets and estimates carried in the solution's sample data, to be measured in your own pilot: 100% of notes read, against an estimated 5% before; a median of 6.6 hours from the call to a referral, against an estimated six days; and 38 false alarms a month to clear, against 1,212 on the sample keyword list.

The design target cuts the wait for a sample from three days to minutes

Estimated days for one offer of value: sampled review, and the solution's design target. Measure both on your own notes

Sampled review, estimatedDesign target
Rep writes or dictates and files0.5 days0.2 days
Note waits to be picked for review3 days0.02 days
Reader recognizes the offer1 day0.01 days
Gathering the four facts1 day0.03 days
Escalation to investigators0.5 days0.02 days

Illustrative · replace with your own numbers

Show the numbers
Sampled review, estimatedDesign target
Rep writes or dictates and files0.5 days0.2 days
Note waits to be picked for review3 days0.02 days
Reader recognizes the offer1 day0.01 days
Gathering the four facts1 day0.03 days
Escalation to investigators0.5 days0.02 days
16 · Who reads and who decides

Six agents read and route; the field compliance lead decides each one

In shortEach agent has one job and a written limit. Together they read, cite and propose. A named person decides each route, nothing about a possible inducement closes without a person, and every dismissal goes to the investigations lead for a weekly second look.

Note Reader

Transcribes voice notes, splits each note into numbered sentences, matches products and physicians, and records the call date and time.

Never edits the rep's words. The clock always starts at the call.

Gift & Inducement Spotter

Finds anything of value offered to a health care professional or staff, cites the sentence and checks the four facts. When unsure, it flags.

Never decides that an offer is acceptable.

Off-label & Language Checker

Finds unsolicited questions on unapproved uses, ages and doses, and absolute, comparative or beyond-the-label wording. Cites the rule and proposes the approved line.

Never writes a new claim. Alternatives quote approved material.

Insight Extractor

Turns access barriers, objections, competitor mentions and unmet needs into de-identified records, each linked to its sentence.

Never carries patient details. Compliance issues are never insights.

Router & Clock Keeper

Proposes one route per finding and sets the due time from the call, under your procedure.

Never moves a possible inducement on its own. Those always wait for a person.

Rep Follow-up Writer

When a fact is missing, such as an amount, a recipient or a receipt, drafts one short CRM message and attaches the answer to the referral.

Never asks for more than what is missing.

Lena decides, Grace takes a second look, Omar answers, Priya coaches

Decides each routeField compliance leadSends, coaches, escalates or dismisses. A dismissal needs a reason. Lena Ortiz in this example.
Second lookCompliance investigations leadReceives escalations with the four facts, and reviews weekly anything closed. Grace Whitaker in this example.
Answers in writingMedical Information leadAnswers each unsolicited request. Sales has no input on the content. Omar Haddad in this example.
CoachesDistrict managerReceives the sentence, the rule and the approved line for each rep. Priya Ranvelle in this example.

The agents work from the words in the note. A person's decision protects the rep as well as the company: a flag becomes a finding only after a person has decided, with the audio and the sentence in front of them.

17 · What goes in and out

CRM notes in; cited escalations, spend records and Medical Information requests out

In shortThe solution connects to the systems field and compliance teams already run, reads the notes where they live and writes each decision back. It is built for large field forces, with roles, maker-checker and an audit trail. Your rules are settings, and they travel with the record of who changed them.

The notes

  • CRM call notes and call reports
  • Voice notes from the CRM app
  • Physician master list, for names and specialties

Your standards

  • Labels and approved material
  • Compliance and medical procedures
  • Meal and gift limits, promotional standards
Agents read, cite and propose Every note, typed or spoken, against your own rules
A person decides each route
Every finding cites its sentence

Outputs

  • Highlighted call notes, each finding tied to its sentence
  • Compliance escalations with the clock from the call
  • Gift and meal records for Open Payments reporting
  • Medical Information requests

What changes for the team

  • Compliance decisions with coaching attached
  • De-identified field insights for commercial teams
  • A nightly match of referrals to cases

Case, spend and Medical Information systems: where the routes end

Escalations go to the compliance case system, meals to the spend system and questions to the Medical Information system. Acknowledgments come back, and each night every referral is matched to its case or record. A person can also ask about any note, clock or referral in plain words, and the answer points back to the sentence.

Built for commercial compliance at field force scale: roles, records and security

What your team needsHow it works
Roles and maker-checkerMaker-checker means one person acts and a second reviews. Agents propose, the lead decides, the investigations lead reviews what was closed. Each is a separate role you assign.
Audit trailEvery agent step, decision, rule change and setting change is recorded with who and when. Notes are never edited: a correction is a new version.
ScaleReads the whole field force's notes each night and new voice notes as they arrive, with the same check on each.
Your rulesClock start, deadlines, what the agents look for, nudges and coaching are settings, versioned. A longer deadline waits for the investigations lead's approval.
Fair treatment of repsFindings work from the words of the note, with the audio and the sentence on screen for the person deciding.
PrivacyInsights carry no patient details. Access to notes and cases follows your roles.
SecuritySOC 2 Type II audited, with information security managed to ISO 27001. For rules such as 21 CFR Part 11, these are controls that support your compliance. Whether your use meets a given rule is for your own quality and legal teams to decide.
Part C · Are you ready to automate?

Automating call note review: what a missed offer costs, what it returns and how to test it

You run field compliance, investigate cases, answer for the sales force or own the CRM. This part is written for you: what unread notes cost today, what reading all of them could return, whether your team is ready, and what to ask any vendor of call note monitoring software, including us.

18 · What unread notes cost

What an unread call note costs you: settlements at one end, monitor hours and false alarms at the other

In shortYour largest exposure is rare and very expensive, and the steady cost is reviewer time spent on the wrong notes. Public figures frame the first. Nobody publishes the second, so count it yourself in a week.

$46M+

total for one company's kickback resolution in August 2026, with a five-year integrity agreement that names call notes.19,42

Veloxis, with admissions
$1.55M

for Open Payments reporting in that same resolution, which DOJ called the largest such recovery since the 2010 law.19

Veloxis, 2026
1,297

whistleblower suits filed in fiscal 2025, the most in a single year, across all industries.40

Department of Justice
Reading every note by hand would take more than five full-time people

Hours a year at 320,000 notes and 2 minutes a note, by share of notes read. About 2,000 hours make one working year. Our assumptions: use your own

5% sample533 hours
25% sample2,667 hours
Every note10,667 hours

Illustrative · replace with your own numbers

Show the numbers
Share of notes readReader hours a year
5% sample533 hours
25% sample2,667 hours
Every note10,667 hours
What we could not find published. We found no public figure for the share of call notes compliance teams read, the time from a call to a referral, the false-alarm rate of phrase lists, or the recall of any AI reader on real call notes. Vendors' descriptions come without test results. The 5% and six days in this guide are its sample data's estimates. Measure your own.

Seven numbers to find in a week: your hours, your delay and your misses

The costWhere it hidesHow to find your number in a week
Share of notes readMonthly samples, in a spreadsheet or review toolNotes reviewed last quarter ÷ notes filed last quarter
Days from call to referralA case records when it opened, seldom when the call happenedTake your last 20 referrals: call date against case-open date
Reviewer minutes per noteInside a monitor's general workloadStopwatch 50 notes, short and long
False alarmsHits cleared in seconds and never countedLast month's phrase hits ÷ those you acted on
Hours chasing factsEmails to reps and managersOpen 10 cases and count the messages before the first decision
Meals with weak recordsExpense reports read separately from notesFor 20 meals, compare the note, the attendee list and the expense report
Your miss rateNobody counts what nobody caughtRead 200 notes in full, by hand, and see what your current method missed

The offer no one read, and other costs a monitoring calculator misses

A dinner that happened after allThe difference between stopping an offer on Wednesday and finding the receipt in a sample next month.
A rep who never got coachedA claim repeated for months, because the person who could have corrected it read about it too late.
Your insider's frustrationThree of the four matters in section 9 began with a whistleblower suit. Someone who raised a concern and saw nothing happen is a risk no one prices.
Questions that went unansweredA doctor's real question about an unapproved use that never reached Medical Information, left for the rep to answer or drop.
19 · Your return

What reading every call note returns when you count monitor hours against its yearly cost

In shortPut in your own numbers. The defaults are assumptions, marked as such. The calculator values reviewer time only: reading, clearing false alarms and chasing facts. It leaves out the main reason to read every note, the case you catch early, because no honest formula prices that.

False alarms, fact-chasing and coverage: where call note monitoring pays

Reviewer time

False alarms you stop clearing

Fewer wrong hits means more time on the right ones. Test it on your own notes.

12 × (false alarms a month today − after) × minutes each ÷ 60
Investigator time

Facts already gathered

A referral arrives with who, to whom, what and in return for what, and any question to the rep already drafted.

referrals a year × (hours today − hours after)
Coverage

Every note read

When a first pass costs little, you can stop sampling. Your risk view then covers everyone.

notes read ÷ notes filed
Speed

Hours from the call

An offer caught in hours can often still be stopped, and a claim coached before it spreads.

median hours, call to referral, measured on real referrals

Your hours back across a year of 320,000 call notes

Every default is an assumption for you to replace. The volume and false alarm figures come from this guide's fictional company: 1,284 notes a weekday over about 250 weekdays, and its sample keyword list.

Your notes and how you read them
False alarms
Referrals and cost
Illustrative yearly value
Hours reading your sample today0
Hours clearing false alarms released0
Hours gathering facts released0
All hours released, valued$0
After your yearly cost$0
Notes nobody reads today0
Hours to read every note by hand0

Formulas, per year:
Sample hours = notes × share read × minutes ÷ 60
False alarm hours = 12 × (today − with automation) × minutes ÷ 60
Fact hours = referrals × (hours today − hours with automation)
After your cost = all hours × hourly cost − yearly cost
Notes unread = notes × (1 − share read)

This assumes the sample reading stops. If your monitors keep a quality sample, take that time back out. Decisions still take people, and this does not value them. Not counted: cases caught early, coaching, field insights, ride-along time. Released hours count as value only when you decide what they are for.

At these assumptions, most released hours come from gathering facts

Hours released a year at the calculator's defaults. If your cases already arrive complete, this result shrinks a lot

Gathering factsClearing false alarmsReading the sample
3,423 hours a year1,950 h939 h533 h

Illustrative · replace with your own numbers

Show the numbers
Gathering factsClearing false alarmsReading the sample
3,423 hours a year1,950 h939 h533 h
20 · Readiness check

How ready your field compliance team is: notes, policies, clocks, owners and tests

In shortPick the answer closest to your team today. Eight questions score 0 to 2, and the last is for reflection. The meter adds up as you go, and each question says why it matters and what a strong answer sounds like.

1
Notes you can reach

Can you export a year of call notes, with call dates, reps and products, typed and spoken?

Why it mattersA test needs real notes, and a clock needs the call date. Audio needs its own check.
A strong answer"Yes, from the CRM, with call date and filing date, and voice files kept beside the text."
2
Who owns each route

Is there a named person who decides where a flagged note goes, and a named owner at each destination?

Why it mattersFlags without an owner become a list nobody opens, and now you have a record of knowing.
A strong answer"The field compliance lead decides. Investigations, Medical Information and Spend each have an owner."
3
Written policies to read against

Do you have current, findable text for meals, gifts, promotional standards and unsolicited requests, and the current label and approved material for each product?

Why it mattersA finding should cite the rule. A policy that lives in slides or in people's heads cannot be cited.
A strong answer"Versioned procedures and a library of approved material, kept by product."
4
Your clock

Does your procedure say how fast a possible violation must reach Compliance, and from when?

Why it mattersNo federal rule we found sets this. If you do not define it, nobody can say whether you met it.
A strong answer"One business day from first awareness, and we have decided how that applies to a note filed late."
5
Where findings land

Can your case, spend and Medical Information systems receive a referral and send back an acknowledgment?

Why it mattersA referral sent by email can get lost. A nightly match needs a system on each side.
A strong answer"All three have an interface, and IT has named someone for it."
6
Your baseline

Do you know your share of notes read, days from call to referral and false alarms a month?

Why it mattersWithout a before, no one can say what automation changed. DOJ also asks what human baseline you test AI against.16
A strong answer"Yes, from last quarter, with the method written down."
7
Your people and their rights

Have legal, HR and privacy agreed how reps are told about monitoring, including in states and countries with notice rules?

Why it mattersNew York requires written notice of some monitoring.48 In the EU this is high-risk AI under Annex III from December 2027.46,21 Works councils may have a say.
A strong answer"Notice is written and acknowledged. Legal has the country list."
8
How you will test it

Could you build a test set of past notes with known answers, and decide what recall and false-alarm rate you will accept?

Why it mattersDOJ asks how you measure "accuracy, precision, or recall".16 A vendor's demo answers none of that.
A strong answer"200 notes read by two reviewers, with planted offers, and a target agreed with counsel."
9
The note you would want to have read

For reflection, not scored. Think of the last serious issue your field force had. Was there a note that could have told you earlier, and what would you have done with it that day?

What a score of 0–6, 7–11 or 12–16 asks of your field compliance team

0–6

Explore

Build the baseline first: count the notes you read, time your last 20 referrals, write your clock into a procedure. If you limit free text, decide with legal whether to reopen that. Start with one product's notes.

7–11

Ready to pilot

Run a measured pilot on past notes from one product and two districts, with planted offers. Compare catches, false alarms and hours with your current process, with your people deciding every route.

12–16

Ready to implement

Plan the full field force: your rules, connections to case, spend and Medical Information systems, reps' notice, coaching through managers, and a regular second look at what was closed.

21 · Questions for any vendor

What to ask any call note monitoring vendor about recall, records, voice and reps' rights, including us

In shortA good answer comes with a number measured on your notes, or a screen you can test. Ask to see each of these working. Then ask us the same questions.

A

Does it find offers made in plain words?

A1

What recall and false-alarm rates do you reach on my notes, for each kind of finding?

Why it mattersDOJ asks how you measure these.16 Overall accuracy hides a low catch rate on rare offers.
Strong answer · warning sign
A test on your notes, with planted offers, reported by kind.
One percentage from a demo.
A2

How does it tell a conditional offer from a meal after a talk?

Why it mattersThe words overlap and the meaning differs.
Strong answer · warning sign
Shows the four facts, each cited to a sentence.
A risk score with no reason.
A3

Does it see that a rep declined an off-label question correctly?

Why it mattersOtherwise your best reps get flagged.
Strong answer · warning sign
Records question and response separately.
"We flag all off-label terms."
A4

Can it tell a solicited request from an unsolicited one?

Why it mattersFDA's draft treats them differently.9
Strong answer · warning sign
Reads the order of events, and says when unsure.
Treats any question as unsolicited.
B

Who decides, and what is on record?

B1

Can the system ever close a possible inducement on its own?

Why it mattersIntent needs a person. A wrong closure is worse than a slow one.
Strong answer · warning sign
Never. A closure needs a named person and a reason.
"Above 95% confidence we auto-close."
B2

Show me the record of one decision: note, sentence, rule, person, time.

Why it mattersAn examiner or monitor will ask.
Strong answer · warning sign
One export, including rule versions.
Logs only for the vendor to read.
B3

Is it certified for Part 11 or GxP?

Why it mattersThose cannot be certified for a product. It is a useful test of honesty.
Strong answer · warning sign
"No. Here are the controls and audits we do have."
"Yes, we are Part 11 certified."
B4

What can you connect to, and how is a lost referral noticed?

Why it mattersA referral lost after the flag undoes the catch.
Strong answer · warning sign
A regular match of referrals to cases.
"We send an email."
C

How does it handle voice notes and the people who dictate them?

C1

What is your transcription error on my reps' voices and my drug names?

Why it mattersPublished error rates vary by speaker.45 A misheard word can start a case.
Strong answer · warning sign
Measured on a sample of your audio, by group.
A vendor's general accuracy figure.
C2

Can the person deciding hear the audio at the flagged sentence?

Why it mattersTranscripts can hold invented phrases.44
Strong answer · warning sign
One click from sentence to audio.
Transcript only, audio deleted.
C3

Does it score tone, stress or emotion?

Why it mattersThe EU bars inferring emotions at work from biometric data.47
Strong answer · warning sign
It works from the words.
"Sentiment from voice" sold as a feature.
C4

What do you need from us for EU field forces?

Why it mattersAnnex III point 4(b) lists worker monitoring as high-risk from December 2, 2027.46,21
Strong answer · warning sign
A written plan for the duties, role by role.
"That won't apply to us."
22 · A ten-week pilot

Testing call note review on past notes in ten weeks, with planted offers and a go or no-go

In shortStart with past notes, so nothing is at stake while you measure. Read a sample by hand as your answer key, plant some offers, run the software, and compare. Move to live notes only when your team and counsel are happy with the numbers.

Ten weeks: an answer key first, past notes next, live notes last

An illustrative plan for one product and two districts

Your teamVendor
Baseline and legal sign-off on notice
Answer key: 200 notes read twice, offers planted
Load policies, labels and approved material
Run on past notes and report by kind
Review misses and false alarms; tune rules
Live notes, one district, people deciding
Measure and decide
Week 0246810

Illustrative · replace with your own numbers

Show the numbers
ActivityFromTo
Baseline and legal sign-off on notice02
Answer key: 200 notes read twice, offers planted03
Load policies, labels and approved material13
Run on past notes and report by kind35
Review misses and false alarms; tune rules57
Live notes, one district, people deciding79
Measure and decide910

Catch rate, wrong flags and hours from the call: what your pilot should report

MeasureHow to take itWhat it tells you
Recall by kindFound ÷ present, against your answer key, for each kind of findingWhether it catches offers, the rarest and most serious
Precision by kindCorrect flags ÷ all flags, as decided by your reviewersWhether reviewers will trust it
Planted offers foundCount of offers you wrote in plain words, with no listed termThe direct test of the keyword gap
Hours from call to referralMedian, on live notes, against your baselineThe promise, in your own data
Transcription errorHand-check 50 audio notes across reps, with drug namesFairness to reps, and input quality
Reviewer minutes per decisionTime 50 decisions with the sentence and rule in viewThe real change in workload
The working-session questions: 12 questions for compliance, legal, sales and IT

Bring field compliance, investigations, legal, Medical Information, the sales lead, HR and IT into one room. Each question says why it matters, and what a strong answer and a warning sign sound like.

A

What your field force writes down

A1

Do we allow free text in call notes, and where else do reps write things down?

Why it mattersWriting can move to places no one monitors.3
Strong answer · warning sign
A policy, and an honest view of phone notes.
"We banned free text, so that's solved."
A2

What will reps do once they know every note is read?

Why it mattersNotes can get shorter, or move elsewhere.
Strong answer · warning sign
Plan to track note length and texting patterns.
No one has thought about it.
A3

How will we tell reps this helps them?

Why it mattersNudges before submitting can correct a claim with no case at all.
Strong answer · warning sign
A plain message from sales and compliance together.
Announced as surveillance.
B

How a flag becomes a decision

B1

Once a note is flagged and unread, what is our duty?

Why it mattersA flag sitting in a queue is a record that you could have known.
Strong answer · warning sign
Counsel's view, in writing, and a staffing plan.
"We'll see how many flags there are."
B2

Who sees a flag on a rep before it is decided?

Why it mattersA wrong flag seen by a manager can harm a career.
Strong answer · warning sign
Compliance only, until a person decides.
Dashboards of flags by rep for sales leaders.
B3

What makes a matter a Reportable Event under any agreement we hold?

Why it mattersA CIA's 30 days run from your determination.42
Strong answer · warning sign
Legal owns the test, and the case system records it.
Not linked to monitoring at all.
C

Scope, spend and systems

C1

Which rules do we turn on first, and do speaker programs join them?

Why it mattersOIG has singled out speaker programs,14 and the largest recent matters involve them.37,38
Strong answer · warning sign
A risk-ranked list, with a date for each rule.
Only what the demo showed.
C2

Can we compare notes with expense reports and attendee lists?

Why it mattersVeloxis's false expense reports padded attendee lists.19
Strong answer · warning sign
Same record, same screen.
Two teams, two systems, no match.
C3

Who uses the field insights, and who may not?

Why it mattersCommercial teams want them. Findings on people must stay in compliance.
Strong answer · warning sign
De-identified, with a named owner.
One shared dashboard for everything.
C4

Which states and countries change our notice and our rules?

Why it mattersGift rules and monitoring notice differ by state.23,24,48
Strong answer · warning sign
A list from counsel, built into the rules.
One national rule for everyone.
C5

Who keeps the audio, and for how long?

Why it mattersAudio backs up the transcript, and it is also personal data.
Strong answer · warning sign
A retention rule set with legal and privacy.
Nobody knows where it is stored.
C6

What would make us stop?

Why it mattersA pilot needs a real no-go.
Strong answer · warning sign
Named thresholds, agreed before the start.
"We'll know it when we see it."
23 · Questions people ask

Pharma call note compliance: the questions people search for, answered

In shortFourteen short answers. Each stands alone, so you can send one to a colleague.

What is call note compliance monitoring?

It is reviewing the notes that pharmaceutical sales representatives file after each visit to a prescriber, looking for offers of value tied to prescribing, gifts and meals outside policy, off-label questions and promotional language. Each finding goes to the team that should act on it. Teams may also call it call note review, post-call note monitoring, field compliance monitoring or HCP (health care professional) interaction monitoring.

What is a call note in pharma?

A call note is the short free-text record a pharmaceutical sales representative files after visiting a prescriber, typed in the company's CRM or dictated into its app. It sits beside the call's other details, such as who was seen, which products were discussed and how many samples were left. Compliance teams read these notes because reps tend to write plainly what happened.

What is a field force monitoring program?

It is a formal program that observes and reviews how sales staff deal with health care professionals, and it often appears in a Corporate Integrity Agreement. The agreement the drug maker Veloxis signed in August 2026 requires full-day ride-alongs and Records Reviews, which list field personnel call notes among other records.

Does the Anti-Kickback Statute cover an offer that was never paid?

The statute covers whoever knowingly and willfully "offers or pays" remuneration to induce a federally reimbursed purchase, order or recommendation. So an offer can matter even if nothing was delivered. Whether a given offer breaks the law depends on intent and on the facts, and that is for counsel to judge.

How quickly must a possible kickback reach Compliance?

We found no federal rule that sets a deadline. Companies set their own, and this guide's fictional company uses one business day. A Corporate Integrity Agreement adds a duty to report a probable violation to the federal health department's inspector general (OIG) within 30 days of determining that it exists.

What are the Open Payments thresholds for 2026?

For program year 2026, the Centers for Medicare & Medicaid Services lists $13.82 for a small payment and $138.13 for the yearly total. A payment under the small amount is excluded, until a covered recipient's total for the year passes the higher figure, when all payments must be reported. Reports are due by the 90th day of the following year.

How do you report a meal shared by a group under Open Payments?

Divide the cost by everyone who ate, including office staff and others who are not covered recipients, and report that per-person value for the covered recipients who ate. Accurate attendee lists therefore matter. Food generally available at a large conference, such as buffets and coffee, need not be tracked or reported.

What should a rep do when a doctor asks about an off-label use?

Under FDA's 2011 draft guidance, questions should go to the firm's medical or scientific department, and sales and marketing staff should have no input on the answer. The rep should decline to discuss it, offer a Medical Information response, and record what happened. A rep who raises the use first can turn the follow-up into a solicited request.

Can sales reps talk about unapproved uses after FDA's 2025 guidance?

FDA's January 2025 guidance covers firm-initiated scientific information on unapproved uses, kept separate from promotion and shared by people with specialized training. FDA's page says it is not for current implementation pending a decision by the Office of Management and Budget. It does not make off-label promotion by a general sales call acceptable, so ask counsel before changing field policy.

Should reps be allowed to write free-text call notes?

That is a decision for your legal team. One CRM vendor's 2026 guide says many companies limited free text from the mid-2000s because notes could be used as evidence, and that writing then moved to personal apps and email, which are harder to monitor. The vendor sells a tool for this, and we found no independent count.

Why do keyword lists miss so many offers?

A list finds only the words someone thought of. An offer such as a dinner in return for three new patients uses everyday words, while a listed word like "pediatric" can sit harmlessly in a practice's name. We found no published rates on real notes, so test your own list with offers planted in plain words.

Can AI replace people in call note review?

It can read every note and propose where each finding goes, which people cannot afford to do by hand. It should not decide what a rep intended or close a possible kickback alone. The Justice Department's September 2024 guidance asks what human baseline a company tests AI against, and how it measures accuracy, precision or recall.

Does the EU AI Act apply to monitoring sales reps' call notes?

If you use such a tool on workers in the EU, likely yes. Annex III point 4(b) lists AI used to monitor and evaluate workers' performance and behavior as high-risk, with those rules applying from December 2, 2027 under the AI Omnibus. Inferring emotions at work from biometric data, such as voice, has been banned since February 2, 2025.

Is call note monitoring software 21 CFR Part 11 certified?

No product can be certified for Part 11 or GxP. A vendor can offer controls that support your compliance, such as audit trails and role-based access, and your quality and legal teams decide whether your use meets a rule. FDA's January 2025 draft on AI also leaves out operational uses that do not affect patients, quality or study results.

24 · One-page summary

Call note compliance monitoring on one page: the method, the November 2026 rules, readiness and terms

Print this page

In shortThe whole guide on one screen: the method, the rules as of November 2026, the readiness questions and the terms.

The method
  1. Keep the call date, and read every note against your own written rules.
  2. Tie each finding to its sentence, and keep the audio beside any transcript.
  3. For an offer of value, gather four facts: who, to whom, what, in return for what.
  4. Send off-label questions to Medical Information, after checking what the rep said.
  5. Send claims to a reviewer, with the rule and an approved line.
  6. Log meals with every person who ate, and match notes to expense reports.
  7. A person decides each route. Dismissals need a reason and a second look.
  8. Measure recall, false alarms and hours from the call, then measure again.

Readiness: score 0–2 on eight questions: 0–6 explore · 7–11 pilot · 12–16 implement.

As of November 2026: Open Payments thresholds $13.82 and $138.13 · OIG pharma guidance still 2003, new guide date TBD · FDA unsolicited requests guidance still a 2011 draft · FDA guidance on scientific information final January 2025, not for current implementation · Regeneron but-for cause, three circuits to one · Zafirov vacated September 1, 2026 · DOJ program guidance September 2024 · EU AI Act Annex III from December 2, 2027 · draft Annex 22 and revised Annex 11 still drafts, and outside this work.

14 terms
Call note
Free text a rep files after a visit, typed or spoken.
CRM
The customer system where reps record calls.
Remuneration
The law's word for anything of value.
Inducement
Value offered to win a purchase, order or recommendation.
Four facts
Who offered, to whom, what of value, in return for what.
Off-label
A use, dose or group the approved label does not cover.
Unsolicited request
A question the firm did nothing to prompt.
Medical Information
The team that answers medical questions in writing, apart from sales.
Open Payments
The federal record of what makers give clinicians; the Sunshine Act program.
Covered recipient
A clinician or teaching hospital that Open Payments reports on.
Qui tam
A suit a private whistleblower brings for the government.
CIA
Corporate Integrity Agreement: a multi-year compliance contract with OIG.
Field Force Monitoring Program
Ride-alongs and records review a CIA requires.
Recall and precision
The share of real issues found, and the share of flags that were right.
25 · Sources

Sources

Read November 2026. Regulatory status statements are as of November 3, 2026.

  1. 42 U.S.C. 1320a-7b, Criminal penalties for acts involving Federal health care programs (the Anti-Kickback Statute at subsection (b)), United States Code, govinfo. govinfo.gov
  2. 42 CFR 403.908, Procedures for electronic submission of reports, Code of Federal Regulations, 2025 edition, govinfo. govinfo.gov
  3. Vault CRM Text Monitoring Agent: Saying Yes to Free Text in CRM, A Guide for Legal and Compliance Stakeholders in Life Sciences, Veeva, a vendor's product guide, March 2026. veeva.com
  4. Civil Monetary Penalties Inflation Adjustments for 2025, final rule, 28 CFR Part 85, 90 Fed. Reg. 29445, U.S. Department of Justice, July 3, 2025. govinfo.gov
  5. Civil Monetary Penalties Inflation Adjustments for 2026, notice, 91 Fed. Reg. 43405, U.S. Department of Justice, July 15, 2026. govinfo.gov
  6. Open Payments, Data Collection: reporting thresholds, program years 2026 and 2027, Centers for Medicare & Medicaid Services. cms.gov
  7. 21 CFR 201.128, Meaning of "intended uses", Code of Federal Regulations, 2025 edition, govinfo. govinfo.gov
  8. 21 CFR 202.1, Prescription-drug advertisements, Code of Federal Regulations, 2025 edition, govinfo. govinfo.gov
  9. Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices, draft guidance, FDA, December 2011, docket FDA-2011-D-0868. fda.gov
  10. Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers, FDA, January 2025, docket FDA-2008-D-0053. fda.gov
  11. 21 CFR 203.31, Sample distribution by means other than mail or common carrier, Code of Federal Regulations, 2025 edition, govinfo. govinfo.gov
  12. OIG Compliance Program Guidance for Pharmaceutical Manufacturers, 68 Fed. Reg. 23731, HHS Office of Inspector General, May 5, 2003. govinfo.gov
  13. Compliance Guidance, HHS Office of Inspector General, read November 3, 2026. oig.hhs.gov
  14. Special Fraud Alert: Speaker Programs, HHS Office of Inspector General, November 16, 2020. oig.hhs.gov
  15. Code on Interactions with Health Care Professionals, effective January 1, 2022, PhRMA, sections 2, 3 and 10. phrma.org
  16. Evaluation of Corporate Compliance Programs, updated September 2024, U.S. Department of Justice, Criminal Division. justice.gov
  17. First Circuit holds but-for causation required to demonstrate falsity in kickback-based FCA cases, growing circuit split, Morgan Lewis, February 25, 2025. morganlewis.com
  18. 2025 year in review: FDA drug and device advertising and promotion enforcement, King & Spalding, January 21, 2026. kslaw.com
  19. Veloxis criminal and civil resolution highlights kickback and Sunshine Act risks, Arnold & Porter, August 13, 2026. arnoldporter.com
  20. Eleventh Circuit rejects one constitutional challenge but leaves open questions on FCA qui tam provisions, Morgan Lewis, September 2026. morganlewis.com
  21. Regulatory framework on AI, with the AI Omnibus, Regulation (EU) 2026/1744, European Commission, Shaping Europe's digital future. digital-strategy.ec.europa.eu
  22. 42 CFR 403.904, Reports of payments or other transfers of value to covered recipients, Code of Federal Regulations, 2025 edition, govinfo. govinfo.gov
  23. 18 V.S.A. 4631a, Expenditures by manufacturers of prescribed products, Vermont Statutes. legislature.vermont.gov
  24. Minnesota Statutes 151.461, Gifts to practitioners prohibited, Office of the Revisor of Statutes, 2026 edition. revisor.mn.gov
  25. DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA, "Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries", JAMA Internal Medicine 176(8):1114-1122, 2016. pubmed.ncbi.nlm.nih.gov
  26. 42 CFR 403.902, Definitions, Code of Federal Regulations, 2025 edition, govinfo. govinfo.gov
  27. Deferred Prosecution Agreement and Statement of Facts, United States and Veloxis Pharmaceuticals, Inc., U.S. Department of Justice, August 2026. justice.gov
  28. Settlement Agreement, United States and Veloxis Pharmaceuticals, Inc., recitals and paragraph 1, U.S. Department of Justice, August 2026. justice.gov
  29. Open Payments, Data Overview: Program Year 2025 update, Centers for Medicare & Medicaid Services, modified July 9, 2026. cms.gov
  30. Open Payments, Fiscal Year 2025 Report to Congress, Centers for Medicare & Medicaid Services, Table 2 and Compliance Activities. cms.gov
  31. 42 CFR 403.912, Penalties for failure to report, Code of Federal Regulations, 2025 edition, govinfo. govinfo.gov
  32. Annual Civil Monetary Penalties Inflation Adjustment, 45 CFR 102.3, 91 Fed. Reg. 3665, U.S. Department of Health and Human Services, January 28, 2026, table rows for 42 U.S.C. 1320a-7h(b). govinfo.gov
  33. Kesselheim AS, Mello MM, Studdert DM, "Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints", PLoS Medicine 8(4):e1000431, 2011. pubmed.ncbi.nlm.nih.gov
  34. Bad Ad Program, FDA, content current March 6, 2025. fda.gov
  35. Approved Notes Overview, Veeva CRM Help, a vendor's product documentation. crmhelp.veeva.com
  36. Pujari R, "Using AI to strengthen sales force compliance monitoring in life sciences", Conventus Law, June 25, 2026, written to promote a review tool. conventuslaw.com
  37. Gilead Sciences agrees to pay $202 million to settle claims of kickbacks to doctors for HIV drug prescriptions, CNBC, by NBC Washington, April 29, 2025. nbcwashington.com
  38. Settlement renews focus on speaker program compliance, Porzio, Bromberg & Newman, February 27, 2025. pbnlaw.com
  39. Medtronic to pay over $9 million to settle False Claims Act and Open Payments Program violations, Loeb & Loeb, October 2020. loeb.com
  40. False Claims Act Settlements and Judgments Exceed $6.8B in Fiscal Year 2025, U.S. Department of Justice, January 16, 2026. justice.gov
  41. Twenty-Seven Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991 Through 2017, Public Citizen, March 14, 2018. citizen.org
  42. Corporate Integrity Agreement between OIG and Veloxis Pharmaceuticals, Inc., section III.M, HHS Office of Inspector General, signed August 7, 2026. oig.hhs.gov
  43. Corporate Integrity Agreement between OIG and Endo Pharmaceuticals Inc., section III.K, HHS Office of Inspector General, February 2014. law.shu.edu
  44. AI speech-to-text can hallucinate violent language, on Koenecke et al., "Careless Whisper", Cornell Chronicle, June 11, 2024. news.cornell.edu
  45. Koenecke A, Nam A, Lake E, et al., "Racial disparities in automated speech recognition", PNAS 117(14):7684-7689, 2020. pubmed.ncbi.nlm.nih.gov
  46. EU Artificial Intelligence Act, Annex III, point 4, Regulation (EU) 2024/1689, reading copy. artificialintelligenceact.eu
  47. Red lines under the EU AI Act: the prohibition of emotion recognition in the workplace and education institutions, Future of Privacy Forum. fpf.org
  48. New York Civil Rights Law section 52-c, notice of electronic monitoring, New York State Senate. nysenate.gov
  49. Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products, draft guidance, FDA, January 2025, docket FDA-2024-D-4689. fda.gov
  50. Draft EU GMP Annex 22, Artificial Intelligence, consultation July 7 to October 7, 2025, PIC/S and European Commission. picscheme.org
  51. EudraLex Volume 4, Good Manufacturing Practice guidelines, European Commission, read November 3, 2026. health.ec.europa.eu
Next step

See it on your own call notes.

Explore the solution, or bring a sample of your past call notes, including some you already know should have been referred, and we will read them with you, every finding tied to its sentence.

botminds.ai The complete guide to call note compliance monitoring · November 2026. Cobbleford Pharma, Veltrimab, Dravenzo, Talvoren, Zorelta, Kelvara, every person, practice, payer, restaurant, policy and figure in the example and the screens are fictional. Regulatory status is as of November 2026; check the sources before relying on it. This guide is general information and is not legal advice.